SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GME is trending as the community discusses potential connections to the recent surge in meme stocks, particularly $BYND. Some traders are drawing parallels to the 2021 meme stock craze, while others remain skeptical about GME's ability to replicate similar gains, especially with discussion around Roaring Kitty and warrant issues.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending downwards after an earnings report revealed a significant EPS miss, attributed to a one-time Brazilian tax issue. The community is discussing the impact of this news, potential downgrades, and whether the fundamentals justify the current valuation. Some investors are concerned about plateauing growth amid increased competition and customer alienation, while others see a buying opportunity.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending amidst a sector-wide pullback, leading to community debate about the stock's near-term direction and potential support levels. Discussions include concerns about market manipulation, comparisons to other high-growth stocks, and confidence in the company's long-term potential within the AI data center space. Despite recent price drops, some investors remain optimistic, citing strong fundamentals and potential catalysts.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending following its acquisition of Railbird, a federally licensed exchange, signaling a move into prediction markets and a potential expansion beyond traditional sports betting. The community is discussing the implications of this move, including potential impacts on existing sports betting licenses and competition with other prediction platforms. Overall, the acquisition is viewed as a strategic effort to tap into new markets and diversify revenue streams.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. It also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment offers products and services sold for applications within the data center, communication networks, and commercial and industrial markets in North America and Latin America. The Asia Pacific segment includes products and services sold for applications within the data center, communication networks, and commercial or industrial markets throughout Greater China, Australia and New Zealand, Southeast Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Columbus, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv ($VRT) is trending due to a strong earnings report, exceeding expectations for both revenue and EPS, driving bullish sentiment. The community is focused on the company's AI data center growth potential and partnership with NVIDIA. Vertiv's role in AI infrastructure and data center cooling is also a key talking point.

Tidal Trust II - YieldMax Ultra Option Income Strategy ETF

YieldMax Ultra Option Income Strategy ETF

ULTY is trending as investors discuss recent price declines and NAV erosion, despite consistent weekly dividend payouts; many community members are weighing the pros and cons of reinvesting dividends versus taking them as cash. Some traders suggest the ETF's management should adjust its strategy to stabilize NAV, while others remain committed to the high-yield income, viewing price drops as reinvestment opportunities. Discussions also involve the influence of broader market factors and potential impacts from government policies.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont Corp ($NEM) is trending due to a strong earnings report and a newly authorized $3 billion share buyback program, signaling confidence in the company's future. The community is discussing whether this positive momentum will continue, with some anticipating further gains as gold prices remain elevated. Bullish sentiment surrounds the potential for NEM to reach new highs, driven by solid financials and a favorable outlook for the gold mining sector.

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Minerva Neurosciences Inc

Minerva Neurosciences ($NERV) is trending after securing significant financing to advance its schizophrenia treatment through Phase 3 trials, leading to a large price surge. The community is actively discussing key price levels and the potential for further gains, with some cautioning against chasing the stock after its initial spike. The focus remains on the company's prospects in the schizophrenia treatment market.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

QBTS is trending as investors debate its valuation relative to revenue and potential catalysts. Community discussions revolve around the company's monetization strategy and potential for government contracts amid increasing interest in the quantum computing sector. Some traders are also pointing towards a potential retracement after a large run.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros ($OMER) is trending due to a recent licensing deal with Novo Nordisk potentially worth $2.1 billion, sending the stock soaring. While some community members express concern about potential retracement and short selling, others see long-term value, especially with upcoming FDA decisions. Discussions include potential buyout scenarios, approval timelines, and the impact of the deal on the company's financials.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$RVVTF 
1) relax.  MF only printed $50k worth of shares for this. 
2) I highly suspect the DRDC tested combined therapies.  Maybe DRDC had prior experience with the MH approach in the past?  (They could even have nudged MF to secure the patent before they proceed 😂)  MH + bucc either enhanced effectiveness or perhaps was just a better delivery system.  

Yes, it&#39;s *possible* that MF knows the buccilamine test flopped and he&#39;s trying to generate the next pivot scam before they announce this is a worthless company... But someone has been under the radar buying on a consistent basis since November.  I don&#39;t believe in coincidences.  Michael hasn&#39;t really earned an investor&#39;s trust - but I read him as one of these guys that are like cats - they always end up on their feet somehow; even if they really don&#39;t deserve it.  I&#39;m hoping that&#39;s what we still have here.

Header75

Amarante Scott

StockTwits For Android 

Revive Therapeutics Ltd

 
1) relax.  MF only printed $50k worth of shares for this. 
2) I highly suspect the DRDC tested combined therapies.  Maybe DRDC had prior experience with the MH approach in the past?  (They could even have nudged MF to secure the patent before they proceed 😂)  MH + bucc either enhanced effectiveness or perhaps was just a better delivery system.  

Yes, it's *possible* that MF knows the buccilamine test flopped and he's trying to generate the next pivot scam before they announce this is a worthless company... But someone has been under the radar buying on a consistent basis since November.  I don't believe in coincidences.  Michael hasn't really earned an investor's trust - but I read him as one of these guys that are like cats - they always end up on their feet somehow; even if they really don't deserve it.  I'm hoping that's what we still have here.

Barron

@Barron401k it&#39;s so hard to believe this isn&#39;t just another pump - given all the Buci 16X more effective than NAC Covid pump.  Was all BS? or was the trial just so poorly handled? I would like to think this is real - but Buci Covid seemed so real - so many clinicians even weighed in - lots of scientific commentaries flooded Reddit and ST - and poof - just like that.... Buci failed to meet endpoints - even after unblinded results were combed through - nothing / nada - and no explanation as to how the heck we went from 16X more effective than NAC to shit - I am not trying to be negative / short - just think it&#39;s important to remember what MF is capable of  - he mislead us in a big way with Covid - hope that&#39;s not the case here - sincerely - but his credibility is shot

StockTwits Web

 it's so hard to believe this isn't just another pump - given all the Buci 16X more effective than NAC Covid pump.  Was all BS? or was the trial just so poorly handled? I would like to think this is real - but Buci Covid seemed so real - so many clinicians even weighed in - lots of scientific commentaries flooded Reddit and ST - and poof - just like that.... Buci failed to meet endpoints - even after unblinded results were combed through - nothing / nada - and no explanation as to how the heck we went from 16X more effective than NAC to shit - I am not trying to be negative / short - just think it's important to remember what MF is capable of  - he mislead us in a big way with Covid - hope that's not the case here - sincerely - but his credibility is shot

@Dirtymartini66 
The science was derailed by Big Pharma. 
Times are changing.  I wouldn&#39;t invest another penny in this.  Forget ROIC on this one.  I&#39;m just hopeful for return OF capital in this investment...

 
The science was derailed by Big Pharma. 
Times are changing.  I wouldn't invest another penny in this.  Forget ROIC on this one.  I'm just hopeful for return OF capital in this investment...